CeraMap Platform

About CeraVx

CeraVx is a privately held, pre-revenue biotech company pioneering a novel ceramic microneedle array patch (CeraMap) platform for intradermal drug and vaccine delivery. Its core technology leverages biocompatible ceramic materials and semiconductor manufacturing techniques to create patches that are painless, require lower drug doses, and target skin-resident immune cells. The company, which recently emerged from stealth in late 2024, is positioned as a platform technology provider seeking partnerships with biopharma companies to advance its patches through research and clinical development.

Therapeutic Areas